JPMORGAN CHASE & CO - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is and the CUSIP is 00973Y908. A total of 5 filers reported holding AKERO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,741,102
+27.5%
251,900
+17.7%
0.00%0.0%
Q2 2023$9,991,660
+1640.7%
214,000
+1326.7%
0.00%
Q1 2023$574,000
+69729.7%
15,0000.0%0.00%
Q4 2022$82215,0000.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 18,300$700,1580.00%
JANE STREET GROUP, LLC 122,700$4,694,5020.00%
SIMPLEX TRADING, LLC 21,000$8030.00%
JPMORGAN CHASE & CO 15,000$574,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of AKERO THERAPEUTICS INC shareholders